Axogen Insider Trades
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 25 · $14.04M
- Shares bought / sold
- 0 / 391.15K
- Net activity
- Net selling $14.0 million
Axogen insider activity
Over the last 12 months, Axogen insiders reported 68 transactions on SEC Form 4: 0 open-market purchases and 25 sales. Insiders bought $0 and sold $14.0 million worth of stock, for net insider selling of $14.0 million. The largest seller was Began Marc A, with $3.6 million in reported sales.
The most recent filing shows TYNDALL JOSEPH A. (Director) selling 3,500 shares at $49.70 on Sep 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AXGN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AXGN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 2, 2026 | TYNDALL JOSEPH A.Director | Sale | 3,500 | $173.94K | Form 4 |
| Aug 11, 2026 | Wendell Amy McBrideDirector | Sale | 13,353 | $646.59K | Form 4 |
| Aug 11, 2026 | Wendell Amy McBrideDirector | Option exercise | 13,353 | $198.29K | Form 4 |
| Aug 10, 2026 | Began Marc AEVP & General Counsel | Sale | 67,500 | $3.20M | Form 4 |
| Aug 10, 2026 | Began Marc AEVP & General Counsel | Option exercise | 67,500 | $550.80K | Form 4 |
| Aug 7, 2026 | Weiler Kathy JohnsonDirector | Sale | 14,150 | $640.97K | Form 4 |
| Jun 19, 2026 | JOHNSON JOHNDirector | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | TYNDALL JOSEPH A.Director | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | Wendell Amy McBrideDirector | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | Burke William P. Mr.Director | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | Weiler Kathy JohnsonDirector | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | Levine Alan MDirector | Option exercise | 14,150 | — | Form 4 |
| Jun 19, 2026 | THOMAS PAULDirector | Option exercise | 18,867 | — | Form 4 |
| May 8, 2026 | Wendell Amy McBrideDirector | Sale | 1,647 | $70.16K | Form 4 |
| May 8, 2026 | Wendell Amy McBrideDirector | Option exercise | 1,647 | $24.46K | Form 4 |
| May 7, 2026 | Kemp JensChief Marketing Officer | Sale | 4,000 | $173.76K | Form 4 |
| May 7, 2026 | Hartley Lindsey MarieCFO | Sale | 573 | $25.02K | Form 4 |
| May 7, 2026 | Hartley Lindsey MarieCFO | Option exercise | 2,963 | $24.50K | Form 4 |
| May 7, 2026 | Hartley Lindsey MarieCFO | Sale | 478 | $20.87K | Form 4 |
| May 7, 2026 | Hartley Lindsey MarieCFO | Option exercise | 2,500 | $20.50K | Form 4 |
| May 7, 2026 | Quackenbush DorisSales VP | Sale | 3,878 | $168.72K | Form 4 |
| May 7, 2026 | JOHNSON JOHNDirector | Sale | 11,050 | $477.97K | Form 4 |
| May 7, 2026 | JOHNSON JOHNDirector | Option exercise | 11,050 | $77.79K | Form 4 |
| May 7, 2026 | Weiler Kathy JohnsonDirector | Sale | 16,344 | $720.62K | Form 4 |
| May 7, 2026 | Weiler Kathy JohnsonDirector | Option exercise | 16,344 | $113.59K | Form 4 |
| Mar 16, 2026 | DeVinney Erick WayneChief Innovation Officer | Sale | 5,221 | $171.46K | Form 4 |
| Mar 16, 2026 | DeVinney Erick WayneChief Innovation Officer | Option exercise | 11,575 | — | Form 4 |
| Mar 16, 2026 | DeVinney Erick WayneChief Innovation Officer | Tax withholding | 2,870 | $94.25K | Form 4 |
| Mar 16, 2026 | DeVinney Erick WayneChief Innovation Officer | Option exercise | 6,363 | — | Form 4 |
| Mar 16, 2026 | Hartley Lindsey MarieCFO | Tax withholding | 1,968 | $64.63K | Form 4 |
| Mar 16, 2026 | Hartley Lindsey MarieCFO | Option exercise | 5,000 | — | Form 4 |
| Mar 16, 2026 | Hartley Lindsey MarieCFO | Tax withholding | 1,574 | $51.69K | Form 4 |
| Mar 16, 2026 | Hartley Lindsey MarieCFO | Option exercise | 4,000 | — | Form 4 |
| Mar 1, 2026 | DeVinney Erick WayneChief Innovation Officer | Tax withholding | 11,276 | $345.61K | Form 4 |
| Mar 1, 2026 | Kemp JensChief Marketing Officer | Tax withholding | 2,952 | $90.48K | Form 4 |
| Mar 1, 2026 | Began Marc AEVP & General Counsel | Tax withholding | 4,427 | $135.69K | Form 4 |
| Mar 1, 2026 | Began Marc AEVP & General Counsel | Option exercise | 11,250 | — | Form 4 |
| Feb 26, 2026 | Hartley Lindsey MarieCFO | Tax withholding | 6,630 | $211.50K | Form 4 |
| Feb 26, 2026 | Hartley Lindsey MarieCFO | Award | 17,453 | — | Form 4 |
| Feb 26, 2026 | DeVinney Erick WayneChief Innovation Officer | Tax withholding | 10,702 | $341.39K | Form 4 |
| Feb 26, 2026 | DeVinney Erick WayneChief Innovation Officer | Award | 33,780 | — | Form 4 |
| Feb 26, 2026 | Kemp JensChief Marketing Officer | Tax withholding | 15,414 | $491.71K | Form 4 |
| Feb 26, 2026 | Kemp JensChief Marketing Officer | Award | 50,670 | — | Form 4 |
| Feb 26, 2026 | Began Marc AEVP & General Counsel | Tax withholding | 8,753 | $279.22K | Form 4 |
| Feb 26, 2026 | Began Marc AEVP & General Counsel | Award | 33,780 | — | Form 4 |
| Feb 22, 2026 | Hartley Lindsey MarieCFO | Tax withholding | 6,704 | $237.19K | Form 4 |
| Feb 22, 2026 | Hartley Lindsey MarieCFO | Award | 17,500 | — | Form 4 |
| Dec 16, 2025 | Weiler Kathy JohnsonDirector | Sale | 6,580 | $194.44K | Form 4 |
| Dec 16, 2025 | Weiler Kathy JohnsonDirector | Sale | 21,825 | $644.86K | Form 4 |
| Dec 16, 2025 | Weiler Kathy JohnsonDirector | Sale | 18,248 | $539.17K | Form 4 |
| Dec 16, 2025 | Weiler Kathy JohnsonDirector | Option exercise | 21,825 | $151.68K | Form 4 |
| Dec 16, 2025 | Weiler Kathy JohnsonDirector | Option exercise | 18,248 | $128.47K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Sale | 18,248 | $534.89K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Sale | 20,436 | $599.02K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Sale | 5,000 | $146.56K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Option exercise | 18,248 | $128.47K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Option exercise | 20,436 | $128.75K | Form 4 |
| Dec 16, 2025 | Wendell Amy McBrideDirector | Option exercise | 5,000 | $44.75K | Form 4 |
| Dec 15, 2025 | Hartley Lindsey MarieCFO | Sale | 14,812 | $442.29K | Form 4 |
| Dec 15, 2025 | Hartley Lindsey MarieCFO | Option exercise | 14,812 | $122.50K | Form 4 |
| Dec 11, 2025 | Began Marc AEVP & General Counsel | Sale | 13,222 | $396.66K | Form 4 |
| Dec 10, 2025 | DALE MICHAEL DChief Executive Officer | Sale | 25,000 | $750.00K | Form 4 |
| Dec 9, 2025 | TYNDALL JOSEPH A.Director | Sale | 10,860 | $336.41K | Form 4 |
| Dec 9, 2025 | TYNDALL JOSEPH A.Director | Sale | 14,248 | $441.36K | Form 4 |
| Dec 9, 2025 | TYNDALL JOSEPH A.Director | Option exercise | 10,860 | $118.92K | Form 4 |
| Dec 9, 2025 | TYNDALL JOSEPH A.Director | Option exercise | 14,248 | $100.31K | Form 4 |
| Dec 9, 2025 | DALE MICHAEL DChief Executive Officer | Sale | 61,463 | $1.92M | Form 4 |
| Dec 9, 2025 | DeVinney Erick WayneChief Innovation Officer | Sale | 19,517 | $609.09K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4